In the case of HbH thalassemia, O2 delivery was ∼35% reduced at low perfusion because of reduced blood [Hb], but as perfusion accelerates, the disadvantage relative to wild-type blood became less apparent (Fig. 6E). Here, GSTM1 is linked to thalassemia.